NextLab Ventures blev grundlagt med én simpel overbevisning: De bedste ventures bygges ikke af kapital alene, men af mennesker der tør handle hurtigt, fejle smart og iterere konstant. Vi er seks partnere med forskellige ekspertiser – teknologi, marketing, vækst, kommerciel strategi og investering – der har valgt at samle vores kræfter i ét venture studio. Vores tilgang er hands-on. Vi investor ikke bare. Vi bygger med. Vi koder. Vi designer. Vi sælger. Vi skalerer. Side om side med vores portfolio-virksomheder.

Buddy's Choice is a Danish pet wellness brand creating high-quality dietary supplements for dogs. We develop thoughtfully formulated products using carefully selected, well-documented ingredients to support dogs’ health and wellbeing throughout all life stages. Quality and transparency are at the core of everything we do. Our products are produced in EU-approved and GMP+ certified facilities and made without unnecessary additives. Our goal is simple: to make it easier for dog owners to support their dog’s everyday health with reliable, effective solutions.

Tid is a watch startup challenging the assumption that products should be designed for a single, default body and identity. Most watches are built around narrow aesthetic and ergonomic norms, leaving many people adapting themselves to the object rather than the other way around. We design unconventional, modular timepieces that prioritize fit, expression, and personal meaning over tradition. The problem we solve is not accuracy of timekeeping, but relevance: creating objects that reflect diverse bodies, lives, and ways of being in the world.

AUTOLYZER is transforming the way vehicle damage is assessed. Powered by AI, computer vision, and machine learning, our platform automates the entire damage inspection process—making it faster, more accurate, and fully transparent. We reduce manual effort, eliminate subjective estimates, minimize fraud risk, and help repair shops and insurers operate with greater efficiency and trust.

Testflow is a Norwegian SaaS platform that makes it fast and easy for companies to test products and services with real users through access to over 120,000 test participants. Our customers include some of Norway's largest companies such as Skatteetaten, DNB, Vipps, VY, and Norsk Helsenett. We have facilitated over 12,000 user tests through our platform, making it faster and easier for companies to gather valuable user insights.

Clubmate is a sales and fundraising platform built for sports clubs. Clubs rely on volunteers, spreadsheets, and scattered tools to run lotteries, sell tickets, collect payments, and manage supporters which creating unnecessary admin and lost revenue. We solve this by bringing digital lotteries, ticketing, fundraising, CRM, discount booklets, and kiosk/merch sales into one simple platform. The result: clubs sell more, spend less time on administration, and get clearer control of cash flow.

Arcana is building new AI-powered technologies that enable long-term human health monitoring through label-free protein detection and proprietary photonics technology, designed to support health monitoring at home. By combining photonics and artificial intelligence, Arcana reads biological signals directly—without labels or reagents—making it possible to generate continuous insight into health over time. Instead of relying on infrequent lab tests or reacting to late-stage symptoms, Arcana focuses on capturing early biological signals that reflect how the body responds to everyday physiological processes such as stress, recovery, and aging. Our mission is to support long-term health and longevity by shifting healthcare from reactive treatment to proactive insight. We believe health should be understood as a trajectory rather than a snapshot, and that high-quality biological data is the foundation for better decisions, more timely interventions, and healthier lives. Arcana is a deep-tech company operating at the intersection of photonics, biology, and artificial intelligence. We work on challenging problems that demand scientific rigor, long-term thinking, and close collaboration across disciplines. Our work spans hardware development, software engineering, data science, and applied biology, with a shared focus on translating complex biological signals into meaningful, real-world impact. If you are motivated by first-principles thinking, enjoy working across boundaries, and want to help shape the future of health and longevity, we invite you to apply.

Moder is the future of resort and hotel management, custom-built for experience-driven hospitality. Our platform lets hospitality businesses run rooms, activities, rentals, dining, and experiences in one place. No more juggling ten systems while whispering “why me” into a coffee mug. Built in Finland and developed hand in hand with pioneering resorts across the Nordics, Moder is growing fast. Our customers serve both leisure and business travelers, and we work closely with them to understand what actually moves the industry forward. Hint: less admin, more hospitality. We’re a focused, remote-first early scaleup with big ambitions and zero unnecessary meetings. If you want to build meaningful tech for an industry that’s finally getting the tools it deserves and appreciate the occasional terrible hospitality pun, you’ll fit right in.

Viven is a healthtech / femtech company. We're building AI-driven online clinic that helps +35-year-old women monitor and improve their hormonal and overall health during their perimenopausal years.

Hos Modeva hjælper vi virksomheder med at tiltrække flere besøgende – og omdanne dem til loyale kunder. Vi hjælper ambitiøse virksomheder med at være til stede, hvor deres kunder er til stede: både på Google og i LLM'er såsom ChatGPT. Vi går ind og tager ejerskab for SEO og Google Ads og arbejder med alt fra content til linkbuilding, digital PR og tekniske løsninger.

Earth Miles are building the first loyalty platform for sustainable transport mobility. Replicating the same powerful incentives that drive the multi-billion euro- airline loyalty market and bringing them to sustainable transport. With a core mission to accelerate the modal shift towards greener transport choices.

Only 7.9% of new medicin is approved for phase 1 clinical programs - life saving cures are being scrapped because of poor reproducibility. Today, researchers designing complex in vitro and in vivo experiments jump between many tools that do not talk to each other. Protocols are written in free text, naming is inconsistent, raw data is scattered across drives, and inventory and cell banks are tracked separately. This makes it hard to reproduce experiments, compare results across projects, trace which cell material went into which batch, and satisfy regulatory expectations. Small and mid-sized labs often cannot afford enterprise platforms like Benchling or Dotmatics, so they manually glue everything together and rarely get to use advanced analytics or AI. BioPilot solves this by standardising the full early-to-in-vivo CTR pipeline in one product. Users can register and template in vitro experiments (differentiation, expansion, cryopreservation, device testing, etc.) and in vivo studies (animals, groups, dosing, housing, ethics documents) using fixed ontologies. This gives every experiment a structured schema and a precise schedule of readouts, barcodes and data types to collect. Raw data (FACS, scRNA-seq, imaging, counters, bioreactor logs, etc.) is then automatically linked back to the right experiment, condition and sample. On top of this, BioPilot offers: • Inventory and cell bank tracking that makes it trivial to trace which vial, edit or expansion batch was used where. • Live bioreactor monitoring with alarms (email / phone) to prevent losing expensive batches. • A growing library of free analytical tools, including automated FACS gating, scRNA-seq pipelines and image analysis that can feed results straight back into the experiment records. • A global ontology service for vendors, instruments, cell lines, species and process terms, with a roadmap for a public API. Because everything is structured and queryable, BioPilot makes it much easier to compare experiments, run Bayesian optimisation on process parameters, and let AI suggest next-step experiments. The pricing is kept aggressively low (free tier plus a simple paid tier based on storage), so smaller biotech and academic groups can access capabilities that are normally reserved for organisations with large software budgets. In short, BioPilot aims to become the operating system for cell therapy R&D: a single, affordable platform where experiments are planned, executed, monitored and analysed in a way that is standardised enough for automation and flexible enough for real-world biology.

TaCtrl.ai is a Norwegian technology company that develops advanced software for the transport and logistics industry. Our cloud-based SaaS platform is designed to optimize and simplify administration in modern transport companies. It is used today both in Norway and internationally. The system streamlines workflows across the entire organization and manages all key administrative processes related to, for example, shift planning, working hours, payroll data, and driving and rest time. Everything is based on real-time data and gathered in one place, giving drivers, administrators, and management an easier workday. Our team has extensive experience in both transport and technology, and deep knowledge of the processes, opportunities, and challenges within the industry. This is also the foundation for how we work: closely together with our customers—through development, delivery, and everyday operations. The result is user-friendly solutions that provide full control over company operations. TaCtrl.ai – a new standard for transport administration.

Tendavo is an AI-driven growth partner that helps small and medium-sized companies win public procurements. We are tackling one of the world's largest but most neglected markets: public procurement, worth 15% of the OECD countries' GDP. We have proven product-market fit, strong profitability, and a founding team from McKinsey, Kivra, and Handelsbanken. We are also part of the SSE Business Lab, the incubator behind companies like Klarna, Voi, and Legora.

Frank Founders is built for one thing: creating pipeline and growth for B2B SaaS companies through digital marketing. We work with ambitious SaaS teams and take ownership of the strategy and execution needed to drive real revenue. We’re part of the Frank Agency Collective - a group of small, specialized agencies that each operate in a narrow segment and focus on measurable outcomes in their domain. The goal is simple: be the obvious choice for a very specific type of client, and irrelevant to everyone else. Frank Founders is a micro-agency with 100% focus on B2B SaaS. That means you work close to the business: you lead strategy, drive execution, and stay close to the numbers. We expect people to take charge, make decisions, and treat client challenges as their own - and in return, we offer a high degree of freedom, trust, and ownership. Our culture is shaped by three principles: 01 Same side of the table - We work with clients as one team, with shared goals and clear accountability. 02 One size fits nobody - We use proven methods, but always tailor them to the company’s stage, priorities, and commercial reality. 03 Process drives progress - We rely on clear structures, frameworks, and testing to turn complexity into momentum and measurable growth. Day to day, that means a lot of sparring, open feedback (“frankly speaking” is part of how we work), and a strong focus on craft. We share knowledge, clients, and responsibilities across the team and are based in Talent Garden on Holmen in Copenhagen, surrounded by other startups and scaleups.